Article
Significant augmentation of pro-apoptotic gene therapy by pharmacologic bcl-xl down-regulation in mesothelioma.
Cancer gene therapy - 1 Aug 2001
Mohiuddin I, Cao X, Fang B, Nishizaki M, Smythe W R
Abstract excerpt
The ratio of pro-apoptotic (PAP) and anti-apoptotic (AAP) bcl-2 proteins is important in apoptosis regulation. We sought to determine if inhibition of the AAP bcl-xl by sodium butyrate (SB) would augment apoptotic cellular death in mesothelioma when combined with adenoviral pro-apoptotic gene therapy (PAGT) by simultaneously increasing PAP and decreasing AAP in these cells. Human mesothelioma cell lines were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
